Biotech · Private company
American Gene Technologies International Inc.
Track this companyFree. Adds American Gene Technologies International Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AGT103-TPhase 1 · HIVClinicalTrials.gov · fetched Nov 12, 2026
- Antiretroviral Therapy Interruption(ATI)HIVClinicalTrials.gov · fetched Nov 12, 2026
- Gene modified therapyHIVClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-TENROLLING_BY_INVITATION · started Aug 29, 2022ClinicalTrials.gov NCT05529342 · fetched Nov 12, 2026
- An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral TherapyUNKNOWN · started Jul 19, 2022ClinicalTrials.gov NCT05540964 · fetched Nov 12, 2026
- Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral TherapyPHASE1 · COMPLETED · started Oct 12, 2020ClinicalTrials.gov NCT04561258 · fetched Nov 12, 2026
- Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive IndividualsUNKNOWN · started Jul 25, 2017ClinicalTrials.gov NCT03215004 · fetched Nov 12, 2026